Serum Soluble Epidermal Growth Factor Receptor Level Increase in Patients Newly Diagnosed with Type 2 Diabetes Mellitus

Diabetes Metab J. 2018 Aug;42(4):343-347. doi: 10.4093/dmj.2017.0082. Epub 2018 May 2.

Abstract

We analyzed circulating soluble epidermal growth factor receptor (sEGFR) levels in humans. Serum sEGFR levels were higher in subjects with newly diagnosed type 2 diabetes mellitus compared with controls. Serum sEGFR was positively correlated with glycosylated hemoglobin and serum glucose and negatively correlated with serum insulin and C-peptide levels.

Keywords: Biological assay; Diabetes mellitus, type 2; Receptor, epidermal growth factor.